Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3995868 | 0.84 | BHMT (0.35) | BHMTBHMT2 | |
| Alanine SCHEMBL5582473 | 0.83 | BHMT (0.33) | BHMTBHMT2 | |
| Alanine SCHEMBL1409244 | 0.82 | BHMT (0.32) | BHMTBHMT2 | |
| Glycine SCHEMBL6361607 | 0.82 | BHMT (0.36) | BHMTBHMT2 | |
| SCHEMBL2551500 | 0.81 | BHMT (0.38) | BHMTBHMT2 | |
| SCHEMBL3995873 | 0.80 | METAP2 (0.32) | — | |
| Glycine SCHEMBL4005389 | 0.78 | BHMT (0.40) | BHMTBHMT2 | |
| SCHEMBL2260606 | 0.78 | RNPEP (0.44) | BHMTBHMT2 | |
| SCHEMBL5073184 | 0.78 | — | — | |
| SCHEMBL9755602 | 0.76 | BHMT (0.34) | BHMTBHMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11761005-B2 | Translocation and mutant ROS kinase in human non-small cell lung carcinoma | CELL SIGNALING TECHNOLOGY, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-11505833-B2 | Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer | CELL SIGNALING TECHNOLOGY, INC. (US) | 2022-11-22 | — | — | US | disclosed |
| EP-3336181-B1 | EGFR AND ROS1 IN CANCER | CELL SIGNALING TECHNOLOGY INC (US) | 2022-01-12 | — | — | EP | disclosed |
| EP-3936621-A1 | TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA | Cell Signaling Technology, Inc. (US) | 2022-01-12 | — | — | EP | disclosed |
| US-20210371933-A1 | COMPOSITIONS FOR DETECTING MUTANT ANAPLASTIC LYMPHOMA KINASE IN LUNG CANCER | CELL SIGNALING TECHNOLOGY, INC. (US) | 2021-12-02 | — | — | US | disclosed |
| US-20210349095-A1 | ROS KINASE IN LUNG CANCER | CELL SIGNALING TECHNOLOGY, INC. (US) | 2021-11-11 | — | — | US | disclosed |
| EP-3906921-A1 | METHOD OF TREATING LUNG ADENOCARCINOMA | Exelixis, Inc. (US) | 2021-11-10 | — | — | EP | disclosed |
| US-10955416-B2 | Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer | CELL SIGNALING TECHNOLOGY, INC. (US) | 2021-03-23 | — | — | US | disclosed |
| EP-3134084-B1 | METHOD OF TREATING LUNG ADENOCARCINOMA | EXELIXIS INC (US) | 2021-03-17 | — | — | EP | disclosed |
| US-20210062196-A1 | TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA | CELL SIGNALING TECHNOLOGY, INC. (US) | 2021-03-04 | — | — | US | disclosed |
| WO-2002077155-A2 | KERATINOCYTE GROWTH FACTOR-2 | HUMAN GENOME SCIENCES, INC. (US) | 2002-10-03 | — | — | WO | disclosed |
| EP-1196441-A1 | KERATINOCYTE GROWTH FACTOR-2 | Human Genome Sciences, Inc. (US) | 2002-04-17 | — | — | EP | disclosed |
| WO-2001002433-A1 | KERATINOCYTE GROWTH FACTOR-2 | HUMAN GENOME SCIENCES, INC. (US) | 2001-01-11 | — | — | WO | disclosed |
| EP-1054900-A1 | THERAPEUTIC USES OF KERATINOCYTE GROWTH FACTOR-2 | Human Genome Sciences, Inc. (US) | 2000-11-29 | — | — | EP | disclosed |
| EP-1041996-A1 | KERATINOCYTE GROWTH FACTOR-2 FORMULATIONS | Human Genome Sciences, Inc. (US) | 2000-10-11 | — | — | EP | disclosed |
| EP-0948515-A1 | HUMAN B-CELL TRANSLOCATION GENES-2 AND 3 | HUMAN GENOME SCIENCES, INC. (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1999041282-A1 | THERAPEUTIC USES OF KERATINOCYTE GROWTH FACTOR-2 | HUMAN GENOME SCIENCES, INC. (US) | 1999-08-19 | — | — | WO | disclosed |
| WO-1999032135-A1 | KERATINOCYTE GROWTH FACTOR-2 FORMULATIONS | HUMAN GENOME SCIENCES, INC. (US) | 1999-07-01 | — | — | WO | disclosed |
| WO-1998012204-A9 | HUMAN B-CELL TRANSLOCATION GENES-2 AND 3 | — | 1998-08-27 | — | — | WO | disclosed |
| WO-1998012204-A1 | HUMAN B-CELL TRANSLOCATION GENES-2 AND 3 | HUMAN GENOME SCIENCES, INC. (US) | 1998-03-26 | — | — | WO | disclosed |